Ypsomed Holding AG
YPSN
Classifica tra le azioni
#2948
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and... Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
Prezzo delle azioni
$469.39
Capitalizzazione di mercato
$6.17B
Variazione (1 giorno)
1.63%
Variazione (1 anno)
18.98%
Paese
CH
Scambia Ypsomed Holding AG (YPSN)
Categoria
Healthcare
Ricavi di Ypsomed Holding AG (YPSN)
Ricavi nel Oct 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Ypsomed Holding AG, i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Ypsomed Holding AG da 2002 a 2026
Ricavi alla fine di ogni anno
| Anno | Ricavi | Cambia |
|---|---|---|
| 2025 | $847.04M | 39.34% |
| 2024 | $607.88M | 11.82% |
| 2023 | $543.61M | 7.97% |
| 2022 | $503.49M | 17.75% |
| 2021 | $427.58M | 4.29% |
| 2020 | $409.99M | -10.08% |
| 2019 | $455.95M | -6.76% |
| 2018 | $489.00M | 25.91% |
| 2017 | $388.37M | 10.90% |
| 2016 | $350.19M | 10.82% |
| 2015 | $316.01M | 1.22% |
| 2014 | $312.21M | 21.22% |
| 2013 | $257.56M | -6.31% |
| 2012 | $274.90M | 3.86% |
| 2011 | $264.69M | 9.99% |
| 2010 | $240.64M | 0.57% |
| 2009 | $239.28M | -17.28% |
| 2008 | $289.26M | 26.94% |
| 2007 | $227.87M | -4.32% |
| 2006 | $238.15M | 17.72% |
| 2005 | $202.31M | 38.65% |
| 2004 | $145.92M | 43.99% |
| 2003 | $101.34M | 69.52% |
| 2002 | $59.78M | 0.00% |
Ricavi di aziende simili o concorrenti
| Azienda | Ricavi | Differenza nei ricavi | Il paese |
|---|---|---|---|
| $6.04B | - |
IE
|
|
| - | - |
CN
|
|
| - | - |
CH
|
|
| - | - |
CN
|
|
| $352.16M | - |
KR
|
